Patent Assignment
Reel/Frame 021487/0575
Change of Name
Recorded: 2008-09-05
Pages: 3
Assignor
NASTECH PHARMACEUTICAL COMPANY INC.
Executed: 2008-06-10
Assignee
MDRNA, INC.
3830 MONTE VILLA PARKWAY, BOTHELL, WASHINGTON, 98021
Covered Properties
(2)
Compositions and methods for enhancing delivery of nucleic acids into cells and for modifying expression of target genes in cells
Application:
11/121,566 →
Publication:
US 2006/0040882
Compositions and Methods for Enhanced Mucosal Delivery of Parathyroid Hormone
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 29, 2005
From: CHEN, LISHAN; CUI, KUNYUAN; CHEN, YUCHING; MAYER, SASHA J.
To: NASTECH PHARMACEUTICAL COMPANY INC.
Reel/Frame 016467/0265 →
Assignment of Assignor's Interest
Jan 16, 2008
From: HOUSTON, MICHAEL E., JR., MR.
To: NASTECH PHARMACEUTICAL COMPANY INC.
Reel/Frame 020374/0572 →
Security Agreement (Patents)
Apr 28, 2010
From: MDRNA, INC. FKA NASTECH PHARMACEUTICAL COMPANY INC.
To: CEQUENT PHARMACEUTICALS, INC.
Reel/Frame 024300/0825 →
Release of Security Interest
Jul 30, 2010
From: CEQUENT PHARMACEUTICALS, INC.
To: MARINA BIOTECH, INC. (F/K/A MDRNA, INC.)
Reel/Frame 024767/0466 →
Security Agreement
Feb 15, 2012
From: MARINA BIOTECH, INC; CEQUENT PHARMACEUTICALS, INC.; MDRNA RESEARCH, INC.
To: GENESIS CAPITAL MANAGEMENT, LLC, AS AGENT
Reel/Frame 027712/0200 →
Release of Security Interest
Apr 14, 2014
From: GENESIS CAPITAL MANAGEMENT, LLC, AS AGENT
To: MARINA BIOTECH, INC.; CEQUENT PHARMACEUTICALS, INC.; MDRNA RESEARCH, INC.
Reel/Frame 032685/0158 →